Results 1 to 10 of about 248,256 (115)

Reversión del bloqueo neuromuscular inducido por vecuronio: sugammadex o neostigmina

Revista Cubana de Anestesiología y Reanimación, 2014
Introducción: se han descrito diferencias entre la reversión de los bloqueantes neuromusculares con sugammadex y neostigmina. La mayoría concuerda que los resultados con sugammadex son superiores.
Migdel G. Abreu Darias, Idoris Cordero Escobar, Gisela Pérez Martinez   +2 more
doaj   +4 more sources

[Post-traumatic stress and quality of life of post-COVID-19 patients in primary care]. [PDF]

Aten Primaria, 2022
Becerra-Canales B, Campos-Martínez HM, Campos-Sobrino M, Aquije-Cárdenas GA.   +3 more
europepmc   +1 more source

Duchenne muscular dystrophy

Nature Reviews Disease Primers, 2021
Dongsheng Duan, Nathalie Goemans, Shin’ichi Takeda   +2 more
exaly   +2 more sources

Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the Phase III SPR1NT trial

Nature Medicine, 2022
Kevin A Strauss, Michelle A Farrar Mbbs
exaly  

Onasemnogene abeparvovec for presymptomatic infants with three copies of SMN2 at risk for spinal muscular atrophy: the Phase III SPR1NT trial

Nature Medicine, 2022
Kevin A Strauss, Michelle A Farrar Mbbs, Francesco Muntoni   +2 more
exaly  

Therapeutic approaches for Duchenne muscular dystrophy

Nature Reviews Drug Discovery, 2023
Thomas C Roberts, Kay E Davies
exaly  

Spinal muscular atrophy

Nature Reviews Disease Primers, 2022
Francesco Muntoni, Richard S Finkel
exaly  

Somatic gene editing ameliorates skeletal and cardiac muscle failure in pig and human models of Duchenne muscular dystrophy

Nature Medicine, 2020
Alessandra Moretti, Daniel Sinnecker, Shicheng Sun   +2 more
exaly  

Induced pluripotent stem cells from a spinal muscular atrophy patient

Nature, 2008
Allison D Ebert, Christian L Lorson, Clive N Svendsen   +2 more
exaly  

Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy

Nature Medicine, 2019
Christopher E Nelson, Yaoying Wu, Matthew A Waller   +2 more
exaly